Professional Summary
I am currently pursuing my Ph.D. at NIPER Mohali, where my research focuses on applying Computer-Aided Drug Design (CADD) tools for rational therapeutic development. I have extensive experience with drug discovery platforms such as Maestro, MOE, AutoDock, AMBER, and GROMACS, which I use for the design and analysis of small molecules and macromolecules, including peptides and foldamers, while addressing key issues related to toxicity, selectivity, and stability. My work also explores targeted protein degradation strategies, including the design of PROTACs and molecular glues, as well as the identification of novel E3 ligases to expand the range of degradable targets. In addition, I am deeply interested in integrating machine learning and deep learning techniques into drug discovery, particularly through the use of generative AI for small-molecule design and automation tools to enhance workflow efficiency and accelerate discovery.
Leave your rating